HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Dietary Supplements Business Strategies Advertising, Marketing & Sales

Health, Beauty And Wellness News: FTC, FDA Enforcement, Noosh In Vitamin Shoppe, GNC Tests Store Features

This article was originally published in The Rose Sheet

  • News

Executive Summary

Dr. Schulze's warned on cancer claims; Nutrition 21 ingredients in BPI Sports, Olympus Labs supplements; GNC tests 'experiential' store features, helps promote ZanthSyn; Noosh Almond Protein in Vitamin Shoppe; and FTC says no more, Nobetes.

Table

View full table

Advertisement

Related Content

HBW Insight
FTC's Claimed Authority To Chase Permanent Injunctions, Monetary Relief May Lack Substantiation
HBW Insight
'Free Trial' Plus False Claims Equals More FTC Enforcement In Supplement Market

Topics

Related Companies

Advertisement
Tags:
Dietary Supplements Business Strategies Advertising, Marketing & Sales
UsernamePublicRestriction

Register

RS122559

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By